These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3611264)

  • 1. Rapid determination of the enantiomers of metoprolol, oxprenolol and propranolol in urine.
    Pflugmann G; Spahn H; Mutschler E
    J Chromatogr; 1987 May; 416(2):331-9. PubMed ID: 3611264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of beta-blockers in urine by solid-phase extraction-supercritical fluid extraction and gas chromatography-mass spectrometry.
    Hartonen K; Riekkola ML
    J Chromatogr B Biomed Appl; 1996 Feb; 676(1):45-52. PubMed ID: 8852043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid chromatographic separation of the enantiomers of metoprolol and its alpha-hydroxy metabolite on Chiralcel OD for determination in plasma and urine.
    Balmér K; Persson A; Lagerström PO; Persson BA; Schill G
    J Chromatogr; 1991 Aug; 553(1-2):391-7. PubMed ID: 1787165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the new beta-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography.
    Bühring KU; Garbe A
    J Chromatogr; 1986 Oct; 382():215-24. PubMed ID: 2878004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective determination of metoprolol and its metabolites in human urine high-performance liquid chromatography with fluorescence detection (HPLC-FLD) and tandem mass spectrometry (MS/MS).
    Baranowska I; Adolf W; Magiera S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():79-84. PubMed ID: 26451466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral high-performance liquid chromatographic determination of oxprenolol in plasma.
    Laethem ME; Rosseel MT; Wijnant P; Belpaire FM
    J Chromatogr; 1993 Nov; 621(2):225-9. PubMed ID: 8294544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct high-performance liquid chromatographic determination in urine of the enantiomers of propranolol and its major basic metabolite 4-hydroxypropranolol.
    Herring VL; Johnson JA
    J Chromatogr; 1993 Feb; 612(2):215-21. PubMed ID: 8468379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micellar liquid chromatography: a worthy technique for the determination of beta-antagonists in urine samples.
    Rapado Martínez I; Villanueva Camañas RM; García Alvarez-Coque MC
    Anal Chem; 1999 Jan; 71(2):319-26. PubMed ID: 9949726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the enantiomers of metoprolol and its major acidic metabolite in human urine by high-performance liquid chromatography with fluorescence detection.
    Li F; Cooper SF; Côté M
    J Chromatogr B Biomed Appl; 1995 Jun; 668(1):67-75. PubMed ID: 7550983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple inverse isotope dilution assay for the stereospecific determination of R(+)- and S(-)-oxprenolol in biological fluids.
    Dieterle W; Faigle JW
    J Chromatogr; 1983 Apr; 259(2):311-8. PubMed ID: 6343408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
    Enquist M; Hermansson J
    J Chromatogr; 1990 Nov; 519(2):285-98. PubMed ID: 1979791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol, alprenolol and oxprenolol metabolism in the dog. Identification of N-methylated metabolites.
    Walle UK; Wilson MJ; Walle T
    Biomed Mass Spectrom; 1981 Feb; 8(2):78-84. PubMed ID: 7272467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of metoprolol in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Yilmaz B; Asci A; Arslan S
    J Sep Sci; 2010 Jul; 33(13):1904-8. PubMed ID: 20512810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct enantiomeric resolution of (+/-)-atenolol, (+/-)-metoprolol, and (+/-)-propranolol by impregnated TLC using L-aspartic acid as chiral selector.
    Bhushan R; Arora M
    Biomed Chromatogr; 2003 Jun; 17(4):226-30. PubMed ID: 12833387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of metoprolol and metabolites in urine by capillary column gas chromatography as oxazolidineone and trimethylsilyl derivatives.
    Gyllenhaal O; Hoffmann KJ
    J Chromatogr; 1984 Aug; 309(2):317-28. PubMed ID: 6480783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluorometric determination of propranolol and its metabolite n-desisopropylpropranolol in plasma and urine by direct meausrement of thin-layer chromatographic plates (author's transl].
    Schäfer M; Geissler HE; Mutschler E
    J Chromatogr; 1977 Nov; 143(6):607-13. PubMed ID: 556337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of metoprolol enantiomers in plasma and urine using (S)-(-)-phenylethyl isocyanate as a chiral reagent.
    Pflugmann G; Spahn H; Mutschler E
    J Chromatogr; 1987 Oct; 421(1):161-4. PubMed ID: 3429563
    [No Abstract]   [Full Text] [Related]  

  • 19. Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
    Witek A; Przyborowski L
    Acta Pol Pharm; 1997; 54(3):183-6. PubMed ID: 9511444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of propranolol and 4-hydroxypropranolol enantiomers after chiral derivatization using reversed-phase high-performance liquid chromatography.
    Schaefer HG; Spahn H; Lopez LM; Derendorf H
    J Chromatogr; 1990 May; 527(2):351-9. PubMed ID: 2387882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.